Ha YM, Kim M, Bang Y, Choi D, Kim JH, Rhie SJ, Noguchi Y, Kim MG. Large Language Models for World Health Organization-Uppsala Monitoring Centre Drug-Adverse Event Causality Assessment Using Food and Drug Administration Adverse Event Reporting System Cases: Comparative Performance Study. Journal of Medical Internet Research. 2026;28.
Lee S, Kim MG, Trott M, Siskind D, Kim JH. Effects of glucagon-like peptide-1 receptor agonists on anthropometric and adiposity measures in patients with antipsychotic-induced weight gain: A systematic review and meta-analysis. Journal of Psychopharmacology. 2026. (Correspondence)
Park S, Park SJ, Choi HS, Lee H, Kim JH, Jeon HL. Comparative risk of pneumonia and acute exacerbation between P-CAB and PPI use in patients with COPD and GERD. npj Primary Care Respiratory Medicine. 2026;36(1):53. (Co-Correspondence)
Kim SY, Lee H, Kim JS, Kim JH, Jeon HL. Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD. Kidney International Reports. 2026;11(6):106524. (Co-Correspondence)
Jeon J, Jeon J, Dang HT, Choi EH, Kang SY, Yun HY, Chae JW, Kim JH, Lee S. Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function. Pharmaceutics. 2026;18(4):398. (Co-Correspondence)
Tran QT, Bui TT, Ngo LT, Yang BR, Baek IH, Nguyen VH, Lee KA, Yun HY, Chae JW, Lee S, Kim JH, Jung W. Model-Based Meta-Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction-Associated Steatohepatitis Patients. CPT: Pharmacometrics & Systems Pharmacology. 2026;15(2). (Co-Correspondence)
Jang Y, Park J, Kang D, Kim JH, Choi HS, Jeon HL, Lee H. Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis. Journal of Gastroenterology and Hepatology. 2026;41(1):28–40.
Kim M, Kim KE, Kwon JH, Han JY, Kim JH, Kim MG. Transformer-based models for ADR detection: cross-drug validation and benchmarking against large language models. Therapeutic Advances in Drug Safety. 2025;16:20420986251405082.
Je MJ, Go JM, Kim SY, Kim MG, Lee H, Jeon HL, Kim JH. Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study. Therapeutic Advances in Gastroenterology. 2025;18:17562848251356406. (Co-Correspondence)
Kim SK, Kim JH, Moon I, Min J, Park J, Kim MG. Cardioprotective effects of PARP Inhibitors: A meta-analysis of animal studies. Translational Research. 2025;280:29–40. (Co-first)
Kim JH, Han JY, Kwon JH, Kim MG. Cardioprotective effects of PARP inhibitors for platinum-agent induced cardiotoxicity. Investigational New Drugs. 2025;43(2):243–249. (Co-first)
Choi C, Kim MG, Kim JH. Reno-protective effects of xanthine oxidase inhibitors in patients with type 2 diabetes and chronic kidney disease: a systematic review and meta-analysis. Journal of Nephrology. 2025;38(2):393–401. (Correspondence)
Kim HJ, Choi SA, Gu MS, Ko SY, Kwon JH, Han JY, Kim JH, Kim MG. Effects of Glucagon-Like Peptide-1 Receptor Agonist on Bone Mineral Density and Bone Turnover Markers: A Meta-Analysis. Diabetes/Metabolism Research and Reviews. 2024;40(6).
Go JM, Lee JY, Song YK, Kim JH. Trends in Artificial Intelligence Applications in Clinical Trials: An analysis of ClinicalTrials.gov. Korean Journal of Clinical Pharmacy. 2024;34(2):134–139. (Correspondence)
Kim JH. Profiling the Cardiovascular Toxicities of CDK4/6 Inhibitors: A Real-World Pharmacovigilance Study. Cancers. 2024;16(16):2869. (Correspondence)
Kim JH, Song YK. Utilizing temporal pattern of adverse event reports to identify potential late-onset adverse events. Expert Opinion on Drug Safety. 2024;23(9):1183–1190. (First)
Han JY, Seo YE, Kwon JH, Kim JH, Kim MG. Cardioprotective Effects of PARP Inhibitors: A Re-Analysis of a Meta-Analysis and a Real-Word Data Analysis Using the FAERS Database. Journal of Clinical Medicine. 2024;13(5):1218.
Kim JH, Lee G, Hwang J, Kim JW, Kwon JW, Song YK. Performance of Cardiovascular Risk Prediction Models in Korean Patients With New-Onset Rheumatoid Arthritis: National Cohort Study. Journal of the American Heart Association. 2023;12(22). (First)
Kang T, Sun Y, Kim JH, Ta C, Perotte A, Schiffer K, Wu M, Zhao Y, Moustafa-Fahmy N, Peng Y, Weng C. EvidenceMap: a three-level knowledge representation for medical evidence computation and comprehension. Journal of the American Medical Informatics Association. 2023;30(6):1022–1031.
Lee SW, Kim H, Byun Y, Baek YS, Choi CU, Kim JH, Kim K. Incidence of Cardiovascular Disease After Atopic Dermatitis Development: A Nationwide, Population-Based Study. Allergy, Asthma & Immunology Research. 2023;15(2):231–245.
Kim JH, Jeon JY, Im YJ, Ha N, Kim JK, Moon SJ, Kim MG. Long-term taxonomic and functional stability of the gut microbiome from human fecal samples. Scientific Reports. 2023;13(1):114. (Co-First)
Jang HY, Song J, Kim JH, Lee H, Kim IW, Moon B, Oh JM. Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. npj Digital Medicine. 2022;5(1):88.
Kim JH, Hua M, Whittington RA, Lee J, Liu C, Ta CN, Marcantonio ER, Goldberg TE, Weng C. A machine learning approach to identifying delirium from electronic health records. JAMIA Open. 2022;5(2). (First)
Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Natarajan K, Zucker J, Perl Y, Weng C. Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis. JMIR Public Health and Surveillance. 2022;8(5).
Kim MG, Kim M, Kim JH, Kim K. Fine-Tuning BERT Models to Classify Misinformation on Garlic and COVID-19 on Twitter. International Journal of Environmental Research and Public Health. 2022;19(9):5126.
Liu C, Liu H, Ta C, Roger J, Butler A, Lee J, Kim J, Shang N, Weng C. Evaluation of Criteria2Query: Towards Augmented Intelligence for Cohort Identification. Studies in Health Technology and Informatics. 2022;290:297–300.
Kim JH, Butler AM, Ta CN, Sun Y, Maurer MS, Weng C. The potential role of EHR data in optimizing eligibility criteria definition for cardiovascular outcome trials. International Journal of Medical Informatics. 2021;156:104587. (First)
Yuan C, Ryan PB, Ta CN, Kim JH, Li Z, Weng C. From clinical trials to clinical practice: How long are drugs tested and then used by patients? Journal of the American Medical Informatics Association. 2021;28(11):2456–2460.
Lee J, Kim JH, Liu C, Hripcsak G, Natarajan K, Ta C, Weng C. Columbia Open Health Data for COVID-19 Research: Database Analysis. Journal of Medical Internet Research. 2021;23(9).
Sun Y, Butler A, Diallo I, Kim JH, Ta C, Rogers JR, Liu H, Weng C. A Framework for Systematic Assessment of Clinical Trial Population Representativeness Using Electronic Health Records Data. Applied Clinical Informatics. 2021;12(4):816–825.
Kim JH, Ta CN, Liu C, Sung C, Butler AM, Stewart LA, Ena L, Rogers JR, Lee J, Ostropolets A, Ryan PB, Liu H, Lee SM, Elkind MSV, Weng C. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials. Journal of the American Medical Informatics Association. 2021;28(1):14–22. (First)
Sun Y, Butler A, Lin F, Liu H, Stewart LA, Kim JH, Idnay BRS, Ge Q, Wei X, Liu C, Yuan C, Weng C. The COVID-19 Trial Finder. Journal of the American Medical Informatics Association. 2021;28(3):616–621.
Kang T, Turfah A, Kim JH, Perotte A, Weng C. A neuro-symbolic method for understanding free-text medical evidence. Journal of the American Medical Informatics Association. 2021;28(8):1703–1711.
Sun Y, Butler A, Stewart LA, Liu H, Yuan C, Southard CT, Kim JH, Weng C. Building an OMOP common data model-compliant annotated corpus for COVID-19 clinical trials. Journal of Biomedical Informatics. 2021;118:103790.
Lee J, Liu C, Kim JH, Butler A, Shang N, Pang C, Natarajan K, Ryan P, Ta C, Weng C. Comparative effectiveness of medical concept embedding for feature engineering in phenotyping. JAMIA Open. 2021;4(2).
Lee J, Ta C, Kim JH, Liu C, Weng C. Severity Prediction for COVID-19 Patients via Recurrent Neural Networks. AMIA Joint Summits on Translational Science Proceedings. 2021;2021:374–383.
Fang Y, Kim JH, Idnay BR, Aragon Garcia R, Castillo CE, Sun Y, Liu H, Liu C, Yuan C, Weng C. Participatory Design of a Clinical Trial Eligibility Criteria Simplification Method. Studies in Health Technology and Informatics. 2021;281:984–988.
[출원] 연합학습 기반 프라이버시 보존형 생리학적 약동학 모델 예측 보정 방법 및 시스템 (KR 10-2026-0131734)
[출원/등록] 약동학적 변화량 예측 장치 및 방법 (KR 10-2022-0119792 / KR 10-2834-0650000)